CRISPR unicorn Mammoth Biosciences shifts from diagnostics with layoffs

Mammoth Biosciences is taking a big step away from its original ambition of upending the diagnostics business with CRISPR, and has laid off the bulk of its employees working on testing. The Brisbane, CA-based startup laid off 35 people, or less than 20% of its workforce, in March, Mammoth CEO…